SCHEMBL845340

SCHEMBL845340

CN(C)c1ccc(C(=O)N2CCC[C@H]2C(=O)Nc2ccc(/C=C/c3ccc(NC(=O)[C@@H]4CCCN4C(=O)C4CCC4)cc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
LMNA P02545 3/20 0.43
RHOC P08134 1/20 0.43
RHOA P61586 1/20 0.43
NPC1 O15118 1/20 0.43
ROCK2 O75116 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PREP P48147 2/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
RAD52 P43351 1/20 0.39
MAPK1 P28482 2/20 0.39
POLB P06746 1/20 0.39
HTT P42858 1/20 0.39
CNR2 P34972 1/20 0.39
MAPT P10636 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845229 0.93 RHOC (0.48) ALDH1A1LMNARHOCRHOANPC1
SCHEMBL13272503 0.88 LMNA (0.36) ALDH1A1LMNARHOCRHOANPC1
SCHEMBL845599 0.87 RHOC (0.43) ALDH1A1LMNARHOCRHOANPC1
SCHEMBL844961 0.86 RHOC (0.43) ALDH1A1LMNARHOCRHOANPC1
SCHEMBL845255 0.86 CYP2C9 (0.47) ALDH1A1LMNARHOCRHOANPC1
SCHEMBL845478 0.84 NPC1 (0.43) ALDH1A1LMNARHOCRHOANPC1
SCHEMBL844884 0.82 HTT (0.48) ALDH1A1LMNARHOCRHOANPC1
SCHEMBL845234 0.81 RHOC (0.43) ALDH1A1LMNARHOCRHOANPC1
SCHEMBL27006226 0.80 RHOC (0.51) ALDH1A1RHOCRHOANPC1ROCK2
SCHEMBL27012630 0.80 RHOC (0.51) ALDH1A1RHOCRHOANPC1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed